• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Crawford resigns FDA's top post

November 1, 2005

Washington — Lester M. Crawford, DVM, PhD, resigned as commissioner of the Food and Drug Administration (FDA). Crawford was considered the highest ranking veterinarian serving in public office. Andrew von Eschenbach, director of the National Cancer Institute, was named FDA interim director.

WASHINGTON — Lester M. Crawford, DVM, PhD, resigned as commissioner of the Food and Drug Administration (FDA). Crawford was considered the highest ranking veterinarian serving in public office. Andrew von Eschenbach, director of the National Cancer Institute, was named FDA interim director.

Veterinarian and pharmacologist Dr. Lester Crawford directed a 10,000-plus army of FDA regulators and scientists and an estimated $1.8-billion budget.

Advertisement

Crawford's resignation came just two months after the U.S. Senate finally approved his confirmation, which was plagued with setbacks and delays. The move ends his three-year tenure at the agency that included high-profile decisions, such as the withdrawal of the popular painkiller Vioxx from the market. The latest controversy included Crawford's decision to postpone non-prescription sales of morning-after contraception despite its safety blessing from FDA scientists.

He is credited with championing Codex Alimentarius and USDA's Hazard Analysis Critical Control Point System.

Crawford is a member of the National Academy of Sciences Institute of Medicine and is considered an expert in food safety. From 1997-2002, he was director of the Center for Food and Nutrition Policy at Georgetown University and at Virginia Tech.

Related Content:

Regulatory
USDA aims to strengthen handling regulations for exotic animals in exhibition
USDA aims to strengthen handling regulations for exotic animals in exhibition
What you need to know about GFI #256 and the changing landscape of compounding medicine
What you need to know about GFI #256 and the changing landscape of compounding medicine
3 common misconceptions in controlled substance regulations
3 common misconceptions in controlled substance regulations

Advertisement

Latest News

To refer or to not refer

Advice panel for women interested in the veterinary field

AVMA president set to testify before Congress

New Hawaii-based pet CBD brand launches

View More Latest News
Advertisement